Navigation Links
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Date:7/17/2009

information, please visit the Company's Web site at www.biocryst.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that peramivir may not receive emergency use authorization; that the U.S. government may choose not to ship peramivir to the CDC Strategic National Stockpile; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed; that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates; that peramivir or our other product candidates may not receive required regulatory clearances from the FDA or other regulatory agencies; that ongoing and future preclinical and clinical development
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
2. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
3. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Updates Peramivir Clinical Development Plan
6. BioCryst Provides Forodesine HCl Update
7. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
8. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
9. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
10. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
11. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... , Aug. 27, 2014 Sihuan ... or the "Company"), a leading pharmaceutical company with ... China,s prescription drug market, ... Company and its subsidiaries (collectively the "Group") for ... "Period"). Financial HighlightsFor the Six months ...
(Date:8/27/2014)... Aug. 27, 2014  CVS Caremark (NYSE: ... new clinical affiliation with MedStar Health, a leading health ... and the Washington, DC ... health care services for patients. Through this clinical affiliation, ... clinical support, medication counseling, chronic disease monitoring and wellness ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
... PALO ALTO, Calif., Feb. 22, 2011 Telik, Inc. (Nasdaq: ... $0.18 per share, for the three months ended December 31, 2010, ... share, for the comparable period in 2009.  For the year ended ... share, compared with a net loss of $23.7 million, or $0.44 ...
... 2011 drugstore.com, inc. (Nasdaq: DSCM ... clinical skincare, and vision products, today announced that ... upcoming events with the financial community: ... & Telecom Conference Date: February 28, 2011Time: 3:20 ...
Cached Medicine Technology:Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 2Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 3Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 4Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 5drugstore.com to Present at Upcoming Financial Conferences 2
(Date:8/27/2014)... hormone therapy has spawned a prevalent but preventable side ... flashes, according to a study by a Yale School ... study published in the Aug. 27 online issue of ... moderate to severe hot flashes also called vasomotor ... Women with VMS experience more than feeling hot; other ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Ticket ... vs. Chile tickets at Levi’s Stadium in Santa Clara. ... in Santa Clara, California just opened in July and will ... when Mexico takes on Chile. These are two of the ... the 2014 World Cup and will look to continue their ...
(Date:8/27/2014)... August 27, 2014 Sound Telecom, a ... solutions, and cloud-based business communication systems, has unveiled an ... about HIPAA-compliant Secure Text Messaging .” The piece examines ... need to do to remain compliant with HIPAA and ... the article and C.O.O. at Sound Telecom, opens with ...
(Date:8/27/2014)... Port Washington, New York (PRWEB) August 27, 2014 ... long dedicated to protecting the rights of victims injured ... put new rules in place for discovery procedures, specifically ... (MDL) brought over C.R. Bard’s transvaginal mesh devices. (MDL ... System Products Liability Litigation, the United States District Court, ...
(Date:8/27/2014)... 27, 2014 (HealthDay News) -- Pouring half a glass of wine ... to a new study. Researchers asked 74 college students and ... from bottles that had varying amounts of wine in them. The ... Those who had a "rule of thumb" about how much to ... two fingers from the top -- poured less wine than those ...
Breaking Medicine News(10 mins):Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:'Half a Glass' Rule May Curb Overdrinking 2
... For women with human papillomavirus (HPV) infection, use of the ... should not be used to treat the infection, according to ... HPV vaccines were designed to prevent HPV infection and the ... that HPV vaccines could help clear the virus in women ...
... ratio is not a better predictor of coronary heart ... cholesterol and HDL-C, according to a study in the ... and guidelines for coronary heart disease (CHD) prevention emphasize ... or both for CHD risk assessment. But in recent ...
... less likely to develop problem behaviors if their fathers ... University researcher finds. , It is well documented that ... increased risk of developing problems such as aggression, hyperactivity, ... who has a positive relationship with his children ...
... Medical Center researchers have demonstrated using functional magnetic ... in stroke and traumatic brain injury survivors who ... that helps these patients recover lost vision. The ... journal Neurorehabilitation and Neural Repair on Aug. 14, ...
... The number of men in the United States with undiagnosed ... Hispanics and African-Americans no longer more likely than whites to ... issued today. , Study author James P. Smith found that ... diabetes did not know they had the disease, in contrast ...
... of us rely on the bathroom scale to tell us ... be better to keep a tape measure at the ready. ... if body weight still falls within a normal rangemarkedly increases ... the heart and the rest of the body. , The ...
Cached Medicine News:Health News:HPV vaccine does not appear to be effective for treating pre-existing HPV infection 2Health News:HPV vaccine does not appear to be effective for treating pre-existing HPV infection 3Health News:Use of certain lipid measures not more effective in predicting coronary heart disease 2Health News:Children of depressed moms do better when dad is involved, SLU researcher finds 2Health News:Vision restoration therapy shown to improve brain activity in brain injured patients 2Health News:RAND finds cases of undiagnosed diabetes drop sharply 2Health News:RAND finds cases of undiagnosed diabetes drop sharply 3Health News:Pot bellies linked to early signs of cardiovascular disease 2Health News:Pot bellies linked to early signs of cardiovascular disease 3
... These Low Contrast Flip charts contain 5 pages ... on each page. Optotype size is 9.5M. Contrast ... These flip charts can be used at several ... the same test. Each offers a different ...
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... high-performance recording unit suitable for a wide ... require up to 16 input channels. Examples ... The unit is capable of recording at ... per second continuously to disk, and is ...
Medicine Products: